Cite this article
-
APA : Adnan, M., Ahmed, E., & Sahar, A. (2024). Analyzing Euglycemic Diabetic Ketoacidosis Trends Amidst the Rise of SGLT-2 Inhibitors: A Comprehensive Review. Global Pharmaceutical Sciences Review, IX(II), 30-38. https://doi.org/10.31703/gpsr.2024(IX-II).04
-
CHICAGO : Adnan, Muhammad, Ejaz Ahmed, and Aimen Sahar. 2024. "Analyzing Euglycemic Diabetic Ketoacidosis Trends Amidst the Rise of SGLT-2 Inhibitors: A Comprehensive Review." Global Pharmaceutical Sciences Review, IX (II): 30-38 doi: 10.31703/gpsr.2024(IX-II).04
-
HARVARD : ADNAN, M., AHMED, E. & SAHAR, A. 2024. Analyzing Euglycemic Diabetic Ketoacidosis Trends Amidst the Rise of SGLT-2 Inhibitors: A Comprehensive Review. Global Pharmaceutical Sciences Review, IX, 30-38.
-
MHRA : Adnan, Muhammad, Ejaz Ahmed, and Aimen Sahar. 2024. "Analyzing Euglycemic Diabetic Ketoacidosis Trends Amidst the Rise of SGLT-2 Inhibitors: A Comprehensive Review." Global Pharmaceutical Sciences Review, IX: 30-38
-
MLA : Adnan, Muhammad, Ejaz Ahmed, and Aimen Sahar. "Analyzing Euglycemic Diabetic Ketoacidosis Trends Amidst the Rise of SGLT-2 Inhibitors: A Comprehensive Review." Global Pharmaceutical Sciences Review, IX.II (2024): 30-38 Print.
-
OXFORD : Adnan, Muhammad, Ahmed, Ejaz, and Sahar, Aimen (2024), "Analyzing Euglycemic Diabetic Ketoacidosis Trends Amidst the Rise of SGLT-2 Inhibitors: A Comprehensive Review", Global Pharmaceutical Sciences Review, IX (II), 30-38
-
TURABIAN : Adnan, Muhammad, Ejaz Ahmed, and Aimen Sahar. "Analyzing Euglycemic Diabetic Ketoacidosis Trends Amidst the Rise of SGLT-2 Inhibitors: A Comprehensive Review." Global Pharmaceutical Sciences Review IX, no. II (2024): 30-38. https://doi.org/10.31703/gpsr.2024(IX-II).04